Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

classic.clinicaltrials.gov

ClinicalTrials.gov: endometrial cancer | First posted in the last 14 days | Last update posted in the last 2 days

Get the latest updates from ClinicalTrials.gov: endometrial cancer | First posted in the last 14 days | Last update posted in the last 2 days directly as they happen.

Follow now 146 followers

Latest posts

Last updated about 10 hours ago

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

1 day ago

Conditions: Advanced Solid Tumors; Advanced Breast Cancer Interventions: Drug: ETX-636 dose escalation...

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

1 day ago

Conditions: Endometrial Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Dedifferentiated Carcinoma; Endometrial Endometrioid...

NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

1 day ago

Conditions: Endometrial Cancer Sponsors: AstraZeneca; North-Eastern German Society of Gynecological Oncology (NOGGO...

Cohort Study of Intrauterine Diseases

1 day ago

Conditions: Endometrial Cancer; Endometrial Hyperplasia; Endometrial Polyps Interventions: Other: No intervention (observational...

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

1 day ago

Conditions: Gynecologycal Cancer Interventions: Diagnostic Test: muscle sample; Other: blood draw Sponsors...

A Study of LY4175408 in Participants With Advanced Cancer

1 day ago

Conditions: Carcinoma, Non-Small-Cell Lung; Small Cell Lung Carcinoma; Endometrial Neoplasms; Neoplasm Metastasis...

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

1 day ago

Conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid...

Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

2 days ago

Conditions: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid...

A Biomarker Screening Protocol for Participants With Solid Tumors

2 days ago

Conditions: Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Non Small Cell...